Results demonstrated that miR-145, a tumor suppressor involved in tumor angiogenesis, is a direct target of DANCR promoting the derepression of vascular endothelial growth factor (VEGF) in ovarian cancer [76]. This evidence concerns the gene VEGFA and neoplasm.